John Chalmers
Direktor/Vorstandsmitglied bei Prognomix, Inc.
Aktive Positionen von John Chalmers
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Prognomix, Inc.
 Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von John Chalmers
Ehemalige bekannte Positionen von John Chalmers
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
International Society of Hypertension
 International Society of Hypertension Miscellaneous Commercial ServicesCommercial Services The International Society of Hypertension (ISH) was established in 1966 and is committed to promoting and encouraging the advancement of hypertension research. The non-profit company is based in Hampton Hill, UK. The ISH Women in Hypertension Research Committee focuses on improving care for women with hypertension worldwide. Professor Bryan Williams has been announced as the next President of the ISH for the years 2022-2024. | Vorsitzender | - | - |
| Präsident | - | - | |
Royal Prince Alfred Hospital
 Royal Prince Alfred Hospital Hospital/Nursing ManagementHealth Services Royal Prince Alfred Hospital provides general medical and surgical services. The company was founded in 1882 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | 01.01.1972 | - |
| National Health & Medical Research Council | Vorsitzender | - | - |
| Präsident | - | - | |
| Massachusetts Institute of Technology | Corporate Officer/Principal | - | - |
Ausbildung von John Chalmers
| The University of Sydney | Undergraduate Degree |
| The University of New South Wales | Doctorate Degree |
Statistik
International
| Australien | 4 |
| Kanada | 2 |
| Japan | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Chairman | 2 |
| President | 2 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Prognomix, Inc.
Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Health Technology |
Royal Prince Alfred Hospital
Royal Prince Alfred Hospital Hospital/Nursing ManagementHealth Services Royal Prince Alfred Hospital provides general medical and surgical services. The company was founded in 1882 and is headquartered in Sydney, Australia. | Health Services |
| National Health & Medical Research Council | Government |
International Society of Hypertension
International Society of Hypertension Miscellaneous Commercial ServicesCommercial Services The International Society of Hypertension (ISH) was established in 1966 and is committed to promoting and encouraging the advancement of hypertension research. The non-profit company is based in Hampton Hill, UK. The ISH Women in Hypertension Research Committee focuses on improving care for women with hypertension worldwide. Professor Bryan Williams has been announced as the next President of the ISH for the years 2022-2024. | Commercial Services |
- Börse
- Insiders
- John Chalmers
- Erfahrung
